Stock 002872 TIANSHENG PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Tiansheng Pharmaceutical Group Co., Ltd.

Equities

002872

CNE100002QC3

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 05/06/2024 am IST 		5-day change 1st Jan Change
3.55 CNY +2.01% Intraday chart for Tiansheng Pharmaceutical Group Co., Ltd. -14.87% -30.80%
25/04 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection
MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Chongqing Pharmaceutical CO., LTD. completed the acquisition of 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd..
CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021
CI
An unknown buyer acquired 11% stake in Hubei Xianming Medical Apparatus and Instruments Co., Ltd. from Hubei Xianming Medical Apparatus and Instruments Co., Ltd. for CNY 5.1 million.
CI
An unknown buyer acquired Chongqing Xinmei Pharmaceutical Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 0.
CI
Chongqing Pharmaceutical CO., LTD. signed an equity transfer intention agreement to acquire 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 59.6 million.
CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd.
CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Junyao Pharmaceutical Packing Products Co., Ltd. from Chen Yi and Feng Yi.
CI
Tiansheng Pharmaceutical Group Co., Ltd. Announces 2017 Final Distribution Plan, Payable on August 22, 2018
CI
Tiansheng Pharmaceutical Approves the Cash Dividend for the Year 2017
CI
Tiansheng Pharmaceutical Proposes Final Dividend for the Year 2017
CI
Tiansheng Pharmaceutical Group Co., Ltd. agreed to acquire Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd. for CNY 31 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002872 Stock
  4. News Tiansheng Pharmaceutical Group Co., Ltd.
  5. Highlights